NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Roles of NF-κB in health and disease: mechanisms and therapeutic potential

(2009) Ee Tsin Wong et al.   CLINICAL SCIENCE

NF- B Activation Through the Alternative Pathway Correlates with Chemoresistance and Poor Survival in Extranodal NK/T-cell Lymphoma, Nasal Type

(2009) X. Liu et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

NF-κB signalling proteins p50/p105, p52/p100, RelA, and IKKε are over-expressed in oesophageal squamous cell carcinomas

(2009) Mi Ran Kang et al.   PATHOLOGY

The Janus faces of CD40 in cancer

(2009) Angelica S.I. Loskog et al.   SEMINARS IN IMMUNOLOGY

Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis

(2008) Keidai Ishikawa et al.   CANCER

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

Tumor Promoting or Tumor Suppressing of NF-κ B, a Matter of Cell Context Dependency

(2008) Fei Chen et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Lung Cancer

(2008) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE